Tsubota Laboratory Inc. logo

Tsubota Laboratory Inc. (4890)

Market Closed
15 Jun, 06:00
JPX JPX
¥
223. 00
+4
+1.8265%
¥
9.75B Market Cap
- P/E Ratio
- Div Yield
14,900 Volume
- Eps
¥ 219
Previous Close
Add Transaction
Day Range
223 227
Year Range
210 478
Want to track 4890 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

4890 closed today higher at ¥223, an increase of 1.8265% from yesterday's close, completing a monthly decrease of -12.549% or -¥32. Over the past 12 months, 4890 stock lost -34.4118%.
4890 is not paying dividends to its shareholders.
The last earnings report, released on May 18, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on one exchange.

4890 Chart

People also search for

Chordia Therapeutics Inc.
¥ 90
-7.2165%
3-D Matrix Ltd.
¥ 341
-5.0139%
Hyuga Primary Care Co., Ltd.
¥ 1,031
-0.5786%
Kyowakogyosyo Co. Ltd.
¥ 6,950
-0.8559%
A-One Seimitsu Inc.
¥ 2,000
-0.2494%

Tsubota Laboratory Inc. (4890) FAQ

What is the stock price today?

The current price is ¥223.00.

On which exchange is it traded?

Tsubota Laboratory Inc. is listed on JPX.

What is its stock symbol?

The ticker symbol is 4890.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 9.75B.

Has Tsubota Laboratory Inc. ever had a stock split?

No, there has never been a stock split.

Tsubota Laboratory Inc. Profile

Health Care Equipment & Supplies Industry
Healthcare Sector
Mr. Kazuo Tsubota M.B.A., M.D., Ph.D. CEO
JPX Exchange
JP3535700003 ISIN
Japan Country
17 Employees
- Last Dividend
- Last Split
- IPO Date

Overview

Tsubota Laboratory Incorporated is a pioneering company based in Tokyo, Japan, that specializes in the research and development of pharmaceuticals and medical devices. Since its incorporation in 2012, the company has dedicated itself to addressing some of the most common ocular conditions, including myopia (nearsightedness), dry eyes, and presbyopia (age-related difficulty in seeing close objects). By harnessing cutting-edge science and technology, Tsubota Laboratory aims to improve the quality of life for individuals suffering from these conditions through innovative healthcare solutions.

Products and Services

  • Myopia Treatment Solutions

    Tsubota Laboratory develops advanced pharmaceuticals and medical devices aimed at correcting myopia. Leveraging the latest research in ocular health, the company creates solutions that not only aim to improve vision but also to address the underlying causes of myopia, promoting long-term eye health.

  • Dry Eye Remedies

    Understanding the discomfort and potential complications associated with dry eyes, Tsubota Laboratory offers a range of products designed to alleviate symptoms and restore moisture balance. These include specially formulated eye drops and devices that help maintain the natural moisture of the eyes, providing relief for sufferers of this common condition.

  • Presbyopia Correction Devices

    As part of its comprehensive approach to eye care, Tsubota Laboratory also innovates in the development of devices geared towards individuals experiencing presbyopia. The company's solutions focus on enhancing the ability to focus on close objects, thereby improving reading and detailed task performance for those affected by age-related vision changes.

Contact Information

Address: CRIK Shinanomachi E7, Bldg. 2
Phone: 81 3 6384 2866